| Literature DB >> 33357706 |
Annah Lee1, Gabriela Cardoso Dal Pont2, Morgan B Farnell2, Stephanie Jarvis3, Michele Battaglia4, Ryan J Arsenault5, Michael H Kogut6.
Abstract
As the demand for alternatives to antibiotic growth promoters (AGP) increases in food animal production, phytobiotic compounds gain popularity because of their ability to mimic the desirable bioactive properties of AGP. Chestnut tannins (ChT) are one of many phytobiotic compounds used as feed additives, particularly in South America, for broilers because of its favorable antimicrobial and growth promotion capabilities. Although studies have observed the microbiological and immunologic effects of ChT, there is a lack of studies evaluating the metabolic function of ChT. Therefore, the objective of this study was to characterize the cecal metabolic changes induced by ChT inclusion and how they relate to growth promotion. A total of 200 day-of-hatch broiler chicks were separated into 2 feed treatment groups: control and 1% ChT. The ceca from all the chicks in the treatment groups were collected on day 2, 4, 6, 8, and 10 after hatch. The cytokine mRNA quantitative RT-PCR was determined using TaqMan gene expression assays for IL-1B, IL-6, IL-8, IL-10, and interferon gamma quantification. The cytokine expression showed highly significant increased expressions of IL-6 and IL-10 on day 2 and 6, whereas the other proinflammatory cytokines did not have significantly increased expression. The results from the kinome array demonstrated that the ceca from birds fed with 1% ChT had significant (P < 0.05) metabolic alterations based on the number of peptides when compared with the control group across all day tested. The increased expression of IL-6 appeared to be strongly indicative of altered metabolism, whereas the increased expression of IL-10 indicated the regulatory effect against other proinflammatory cytokines other than IL-6. The ChT initiate a metabolic mechanism during the first 10 d in the broiler. For the first time, we show that a phytobiotic product initially modulates metabolism while also potentially supporting growth and feed efficiency downstream. In conclusion, a metabolic phenotype alteration in the ceca of chickens fed ChT may indicate the importance of enhanced broiler gut health.Entities:
Keywords: feed additive; kinome array; metabolism; phytobiotic
Mesh:
Substances:
Year: 2020 PMID: 33357706 PMCID: PMC7772675 DOI: 10.1016/j.psj.2020.09.085
Source DB: PubMed Journal: Poult Sci ISSN: 0032-5791 Impact factor: 3.352
Calculated composition of starter diets. The total basal diet contained 1,365 kcal/lb.
| Ingredients | % |
|---|---|
| Corn | 59.81 |
| SBM 48% | 33.84 |
| Monocalcium phosphate 21 | 1.56 |
| Soy oil | 2.09 |
| Choline chloride | 0.10 |
| Limestone | 1.56 |
| Salt | 0.33 |
| L-lysine HCL | 0.19 |
| DL-methionine | 0.28 |
| Vitamin premix | 0.13 |
| Mineral premix | 0.05 |
| L-Threonine | 0.05 |
| Calculated nutrients, % | 99.99 |
| Protein | 22.00 |
| Calcium | 0.90 |
| Available phosphorus | 0.45 |
| AMEn (Kcal/lb) | 1,365.00 |
| Digestible methionine | 0.59 |
| Digestible total sulfa amino acid | 0.88 |
| Digestible threonine | 0.77 |
| Digestible lysine | 1.18 |
| Choline | 1,256.87 |
| Sodium | 0.16 |
| Potassium | 0.84 |
| Chloride | 0.20 |
Real-time quantitative RT-PCR primer and probe sequences.
| RNA target | Probe/prime sequence | Exon boundary | Accession no |
|---|---|---|---|
| 28S | |||
| Probe | 5′-(FAM)-AGGACCGCTACGGACCTCCACCA-(TAMRA)-3′ | ||
| F | 5′-GGCGAAGCCAGAGGAAACT-3′ | ||
| R | 5′-GACGACCGATTGCACGTC-3 | ||
| IL-1β | |||
| Probe | 5′-(FAM)-CCACACTGCAGCTGGAGGAAGCC-(TAMRA)-3′ | 5/6 | |
| F | 5′-GCTCTACATGTCGTGTGTGATGAG-3′ | ||
| R | 5′-TGTCGATGTCCCGCATGA-3′ | ||
| IL-6 | |||
| Probe | 5′-(FAM)-AGGAGAAATGCCTGACGAAGCTCTCCA-(TAMRA)-3′ | 3/4 | |
| F | 5′-GCTCGCCGGCTTCGA-3′ | ||
| R | 5′-GGTAGGTCTGAAAGGCGAACAG-3′ | ||
| IL-8 | |||
| Probe | 5′-(FAM)-CTTTACCAGCGCGTCCTACCTTGCGACA-(TAMRA)-3′ | 1/2 | |
| F | 5′-GCCCTCCTCCTGGTTTCAG-3′ | ||
| R | 5′-TGGCACCGCCAGCTCATT-3′ | ||
| IL-10 | |||
| Probe | 5′-(FAM)-CGACGATGCGGCGCTGTCA-(TAMRA)-3′ | 3/4 | |
| F | 5′-CATGCTGCTGGGCCTGAA-3′ | ||
| R | 5′-CGTCTCCTTGATCTGCTTGATG-3′ | ||
| Interferon gamma | |||
| Probe | 5′-(FAM)-TGGCCAAGCTCCCGATGAACGA-(TAMRA)-3′ | 3/4 | |
| F | 5′-GTGAAGAAGGTGAAAGATATATCATGGA-3′ | ||
| R | 5′-GCTTTGCGCTGGATTCTCA-3′ |
Figure 1The fold change values based on day tested of the mRNA expression assay for IL-6. These data reflect the averaged replicate experiments (N = 200). The asterisks denote significant differences between the control and 1% ChT groups. Abbreviation: ChT, chestnut tannin.
Figure 2The fold change values based on day tested of the mRNA expression assay for IL-10. These data reflect the averaged replicate experiments (N = 200). The asterisks denote significant differences between the control and 1% ChT groups. Abbreviation: ChT, chestnut tannin.
The top 15 Gene ontology metabolic biological processes (BP) identified at day 4, 6, and 10 comparing 1% ChT–fed birds against control birds.
| Biological processes | Day 4 | Day 6 | Day 10 |
|---|---|---|---|
| Phosphate-containing compound metabolic process | 100 | 132 | 79 |
| Primary metabolic process | 145 | 187 | 122 |
| Protein metabolic process | 99 | 136 | 83 |
| Cellular metabolic process | 142 | 184 | 125 |
| Fatty acid metabolic process | 90 | 19 | - |
| Glucose metabolic process | 11 | 14 | 9 |
| Glycerolipid metabolic process | 18 | 28 | 16 |
| Cellular lipid metabolic process | 37 | 48 | 24 |
| Glycogen metabolic process | 8 | 9 | 6 |
| ATP metabolic process | 13 | 11 | 10 |
| Lipid metabolic process | 38 | 50 | 26 |
| Carbohydrate metabolic process | 21 | 25 | 18 |
| Hexose metabolic process | 13 | 15 | - |
| NAD metabolic process | 8 | 11 | 8 |
| Pyruvate metabolic process | 10 | 11 | 9 |
The hyphens indicate nonsignificant BP based on the FDR.
Abbreviation: ChT, chestnut tannin.
Summarized table of Kyoto Encyclopedia of Genes and Genomes metabolic pathways at day 4, 6, and 10 comparing 1% ChT–fed birds and control birds.
| Metabolic pathways | Day 4 | Day 6 | Day 10 | |||
|---|---|---|---|---|---|---|
| Identified pathways | Number of peptides | Number of peptides | Number of peptides | |||
| PI3K-Akt signaling pathway | 34 | 1.15 × 10−22 | 44 | 4.28 × 10−29 | 24 | 1.11 × 10−13 |
| MAPK signaling pathway | 30 | 1.75 × 10−20 | 49 | 2.32 × 10−37 | 22 | 2.44 × 10−13 |
| Metabolic pathway | 28 | 1.39 × 10−05 | 32 | 4.67 × 10−05 | - | - |
| Insulin signaling pathway | 27 | 5.29 × 10−25 | 27 | 1.30 × 10−22 | 20 | 7.77 × 10−17 |
| AMPK signaling pathway | 21 | 1.19 × 10−18 | 20 | 7.95 × 10−16 | 16 | 3.16 × 10−13 |
| HIF-1 signaling pathway | 18 | 1.82 × 10−16 | 18 | 5.60 × 10−15 | 12 | 6.91 × 10−10 |
| mTOR signaling pathway | 18 | 6.72 × 10−14 | 18 | 2.23 × 10−12 | 18 | 5.53 × 10−14 |
| cAMP signaling pathway | 17 | 2.85 × 10−11 | 13 | 1.79 × 10−06 | - | - |
| Glucagon signaling pathway | 14 | 8.32 × 10−12 | 15 | 1.22 × 10−11 | 11 | 9.36 × 10−09 |
| VEGF signaling pathway | 12 | 7.40 × 10−12 | 17 | 7.06 × 10−17 | - | - |
| Calcium signaling pathway | 11 | 2.42 × 10−06 | 10 | 0.00012 | - | - |
| Glycolysis/Gluconeogenesis | 10 | 5.39 × 10−09 | 10 | 4.75 × 10−08 | - | - |
| GnRH signaling pathway | 10 | 4.43 × 10−08 | 14 | 3.03 × 10−11 | - | - |
| Adipocytokine signaling pathway | - | - | 18 | 3.60 × 10−17 | - | - |
The hyphens indicate less than 10 peptides and not significant for our analysis.
Abbreviation: ChT, chestnut tannin.